Showing 7 posts of 697 posts found.

Roche’s RoActemra recommended for approval

November 26, 2008
Sales and Marketing RA, Roche

European regulators have recommended Roche's RoActemra be approved to treat moderate to severe rheumatoid arthritis. The novel drug, known as …

Roche strikes deal over Tarceva price

November 17, 2008
Sales and Marketing Roche, Taxotere

NICE is set to recommend Roche's lung cancer treatment Tarceva after the company agreed to lower the drug's price. The …

Study boost for Roche’s Actemra

October 30, 2008
Research and Development, Sales and Marketing RA, Roche

New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …

Roche dips on Tamiflu decline

October 24, 2008
Sales and Marketing Roche

Roche's sales dropped 2% to 33.3 billion Swiss francs in the first nine months of 2008, due to a sharp …

GlycArt’s new cancer candidate to be developed with Roche

October 9, 2008
Research and Development, Sales and Marketing GlycArt, Roche

Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …

Meda acquires four Roche products

August 28, 2008
Sales and Marketing Roche

Stockholm-based specialty pharma company Meda has bought four of Roche’s pharma products in a deal worth 120 million Euros – …

Latest news from Datamonitor

July 28, 2008
Sales and Marketing Genentech, Roche

Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …

Latest content